Acuta Capital Partners, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 34Value: $86.2MLatest: 2025Q1

ACUTA CAPITAL PARTNERS, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 34 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "ASND",
  "EWTX",
  "TRVI",
  "INSM",
  "FBRX",
  "RVMD",
  "ARGX",
  "JAZZ",
  "MREO",
  "RCKT",
  "RAPP",
  "TERN",
  "TRML",
  "LQDA",
  "GILD",
  "ARTV",
  null,
  null,
  null,
  "SRZN",
  "UNCY",
  "WHWK",
  null,
  "ZYME",
  "MRK",
  "PRAX",
  "SLNO",
  "CDTX",
  "ELVN",
  null,
  "VERV",
  "VSTM",
  "RARE"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 34
Total Value: 86228809
Accession Number: 0001104659-25-048878
Form Type: 13F-HR
CIK: acuta-capital-partners
Manager Name: Acuta-Capital-Partners

Data Enrichment

85% identified

29 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

34 positions • $86.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:1.2M

Value:$8.9M

% of Portfolio:10.4% ($8.9M/$86.2M)

INSMED Inc

INSM|457669307

Shares:106.1K

Value:$8.1M

% of Portfolio:9.4% ($8.1M/$86.2M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:426.9K

Value:$6.5M

% of Portfolio:7.5% ($6.5M/$86.2M)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:3.4M

Value:$6.1M

% of Portfolio:7.0% ($6.1M/$86.2M)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:265.3K

Value:$5.2M

% of Portfolio:6.1% ($5.2M/$86.2M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:786.0K

Value:$4.9M

% of Portfolio:5.7% ($4.9M/$86.2M)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:67.1K

Value:$4.8M

% of Portfolio:5.6% ($4.8M/$86.2M)

ARGENX SE

ARGX|04016X101

Shares:7.0K

Value:$4.2M

% of Portfolio:4.8% ($4.2M/$86.2M)

Ascendis Pharma A/S

ASND|04351P101

Shares:23.3K

Value:$3.6M

% of Portfolio:4.2% ($3.6M/$86.2M)

Praxis Precision Medicines, Inc.

PRAX|74006W207

Shares:87.1K

Value:$3.3M

% of Portfolio:3.8% ($3.3M/$86.2M)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:125.7K

Value:$2.7M

% of Portfolio:3.1% ($2.7M/$86.2M)

H5870P102

Shares:125.0K

Value:$2.4M

% of Portfolio:2.8% ($2.4M/$86.2M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:66.7K

Value:$2.4M

% of Portfolio:2.7% ($2.4M/$86.2M)

Liquidia Corp

LQDA|53635D202

Shares:153.5K

Value:$2.3M

% of Portfolio:2.6% ($2.3M/$86.2M)

10919W405

Shares:59.7K

Value:$2.2M

% of Portfolio:2.5% ($2.2M/$86.2M)

G4444H101

Shares:187.3K

Value:$2.1M

% of Portfolio:2.5% ($2.1M/$86.2M)

Merck & Co., Inc.

MRK|58933Y105

Shares:23.0K

Value:$2.1M

% of Portfolio:2.4% ($2.1M/$86.2M)

Surrozen, Inc./DE

SRZN|86889P208

Shares:170.0K

Value:$2.0M

% of Portfolio:2.3% ($2.0M/$86.2M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:85.5K

Value:$1.9M

% of Portfolio:2.2% ($1.9M/$86.2M)

Mereo BioPharma Group plc

MREO|589492107

Shares:791.8K

Value:$1.8M

% of Portfolio:2.1% ($1.8M/$86.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	1.2M	QoQ +9.77% (-108.7K) YoY -53.71% (-1.4M)	All Managers (Combined)	$8.9M	10.4% ($8.9M/$86.2M)	QoQ -5.77% (-$548.0K) YoY -62.71% (-$15.0M)
INSMED Inc(INSMcusip457669307)	106.1K	QoQ +1.21% (+1.3K) YoY +71.86% (+44.4K)	All Managers (Combined)	$8.1M	9.4% ($8.1M/$86.2M)	QoQ +11.84% (+$857.0K) YoY +383.29% (+$6.4M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	426.9K	QoQ +21.32% (-75.0K) YoY +63.48% (+165.8K)	All Managers (Combined)	$6.5M	7.5% ($6.5M/$86.2M)	QoQ -9.00% (-$642.5K) YoY +8.58% (+$513.5K)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	3.4M	QoQ +84.40% (+1.6M) YoY +84.40% (+1.6M)	All Managers (Combined)	$6.1M	7.0% ($6.1M/$86.2M)	QoQ +4.03% (+$235.7K) YoY +40.27% (+$1.7M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	265.3K	QoQ -0.78% (-2.1K) YoY -33.02% (-130.8K)	All Managers (Combined)	$5.2M	6.1% ($5.2M/$86.2M)	QoQ -13.21% (-$795.3K) YoY -25.07% (-$1.7M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	786.0K	QoQ +1.81% (+14.0K) YoY NEW(+786.0K)	All Managers (Combined)	$4.9M	5.7% ($4.9M/$86.2M)	QoQ +55.43% (+$1.8M) YoY NEW(+$4.9M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	67.1K	QoQ NEW(+67.1K) YoY NEW(+67.1K)	All Managers (Combined)	$4.8M	5.6% ($4.8M/$86.2M)	QoQ NEW(+$4.8M) YoY NEW(+$4.8M)
ARGENX SE(ARGXcusip04016X101)	7.0K	QoQ +1.63% (-113) YoY NEW(+7.0K)	All Managers (Combined)	$4.2M	4.8% ($4.2M/$86.2M)	QoQ -2.18% (-$93.0K) YoY NEW(+$4.2M)
Ascendis Pharma A/S(ASNDcusip04351P101)	23.3K	QoQ +1.58% (+364) YoY NEW(+23.3K)	All Managers (Combined)	$3.6M	4.2% ($3.6M/$86.2M)	QoQ +15.00% (+$474.7K) YoY NEW(+$3.6M)
Praxis Precision Medicines, Inc.(PRAXcusip74006W207)	87.1K	QoQ +29.09% (-19.6K) YoY -46.30% (-75.2K)	All Managers (Combined)	$3.3M	3.8% ($3.3M/$86.2M)	QoQ -36.47% (-$1.9M) YoY -66.67% (-$6.6M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	125.7K	QoQ +130.77% (+71.2K) YoY NEW(+125.7K)	All Managers (Combined)	$2.7M	3.1% ($2.7M/$86.2M)	QoQ +84.92% (+$1.2M) YoY NEW(+$2.7M)
(cusipH5870P102)✕	125.0K	QoQ NEW(+125.0K) YoY NEW(+125.0K)	All Managers (Combined)	$2.4M	2.8% ($2.4M/$86.2M)	QoQ NEW(+$2.4M) YoY NEW(+$2.4M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	66.7K	QoQ -40.32% (-45.0K) YoY -53.63% (-77.1K)	All Managers (Combined)	$2.4M	2.7% ($2.4M/$86.2M)	QoQ -51.75% (-$2.5M) YoY -49.13% (-$2.3M)
Liquidia Corp(LQDAcusip53635D202)	153.5K	QoQ +11.45% (+15.8K) YoY NEW(+153.5K)	All Managers (Combined)	$2.3M	2.6% ($2.3M/$86.2M)	QoQ +39.79% (+$644.4K) YoY NEW(+$2.3M)
(cusip10919W405)✕	59.7K	QoQ -13.56% (-9.4K) YoY NEW(+59.7K)	All Managers (Combined)	$2.2M	2.5% ($2.2M/$86.2M)	QoQ -13.44% (-$334.7K) YoY NEW(+$2.2M)
(cusipG4444H101)✕	187.3K	QoQ +3.48% (+6.3K) YoY NEW(+187.3K)	All Managers (Combined)	$2.1M	2.5% ($2.1M/$86.2M)	QoQ +11.37% (+$216.1K) YoY NEW(+$2.1M)
Merck & Co., Inc.(MRKcusip58933Y105)	23.0K	QoQ NEW(+23.0K) YoY NEW(+23.0K)	All Managers (Combined)	$2.1M	2.4% ($2.1M/$86.2M)	QoQ NEW(+$2.1M) YoY NEW(+$2.1M)
Surrozen, Inc./DE(SRZNcusip86889P208)	170.0K	QoQ NEW(+170.0K) YoY NEW(+170.0K)	All Managers (Combined)	$2.0M	2.3% ($2.0M/$86.2M)	QoQ NEW(+$2.0M) YoY NEW(+$2.0M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	85.5K	QoQ -2.51% (-2.2K) YoY NEW(+85.5K)	All Managers (Combined)	$1.9M	2.2% ($1.9M/$86.2M)	QoQ -19.67% (-$460.5K) YoY NEW(+$1.9M)
Mereo BioPharma Group plc(MREOcusip589492107)	791.8K	QoQ +1.60% (-12.5K) YoY +99.00% (+393.9K)	All Managers (Combined)	$1.8M	2.1% ($1.8M/$86.2M)	QoQ -34.68% (-$946.0K) YoY +35.68% (+$468.6K)